AI 처방전 준수 도구

집

AI 프롬프트 목록

의료 건강

처방전 감사 어시스턴트

${:__('collect %s',처방전 감사 어시스턴트)}$

의료 건강

임상 지침에 따라 처방전을 자동으로 감사하고, 잠재적인 약물 상호작용 및 용량 위험을 식별하며, 표준화된 감사 보고서를 생성합니다.

프롬프트 내용

복사

Acting as a senior clinical pharmacist in a hospital pharmacy, please conduct a compliance review of the following electronic prescription. The input includes patient demographics, medical history, current medication list, and details of the proposed drug. First, analyze potential drug-drug interactions, particularly focusing on metabolic impacts for patients with hepatic or renal impairment. Next, verify if the dosage aligns with the latest clinical guidelines and patient weight calculations. Finally, identify any contraindications or allergy conflicts, and output the audit conclusion in structured yet natural language, clearly stating whether risks exist, their severity, and suggested adjustments to ensure patient safety.

복사

병원 약국에서 수석 임상 약사로서 다음 전자 처방전의 준수성을 검토하십시오. 입력 데이터에는 환자 인구통계 정보, 병력, 현재 복용 약물 목록 및 제안된 약물의 세부 정보가 포함됩니다. 먼저 간 또는 신장 장애가 있는 환자에 대한 대사 영향에 중점을 둔 잠재적인 약물 간 상호작용을 분석하십시오. 다음으로, 용량이 최신 임상 지침 및 환자 체중 계산과 일치하는지 확인하십시오. 마지막으로, 금기 사항이나 알레르기 충돌을 식별하고, 환자의 안전을 보장하기 위해 위험의 존재 여부, 중증도 및 권장 조정안을 명확히 나타내는 구조화되었지만 자연스러운 언어로 감사 결론을 출력하십시오.

복사

공유 링크를 복사하려면 클릭

의견 (0)

0/300

제출하다

추천

처방전 심사 보조

Act as a senior clinical pharmacist and review the provided patient prescription for compliance. Focus on analyzing potential drug-drug interactions, checking for incompatibilities, verifying if dosages align with the patient's age and renal/hepatic function, and ensuring no contraindications are violated. List all identified risks and provide optimization suggestions or alternatives based on the latest clinical guidelines to ensure medication safety and regulatory compliance.

처방전 심사 보조 도구

Act as a senior clinical pharmacist to review the following prescription for compliance: The patient is a 65-year-old male diagnosed with Stage 2 hypertension and mild renal impairment (eGFR 45ml/min). Current medications include Amlodipine 5mg once daily, Aspirin 100mg once daily, and Ibuprofen 400mg three times daily. Focus on evaluating the renal risks of NSAIDs in this patient population, check for drug-disease contraindications or dosage adjustment needs, and provide specific medication recommendations and risk warnings, ensuring the output is concise and professional.

처방전 감사 어시스턴트

Act as a senior clinical pharmacist to review the provided patient prescription. Focus on analyzing drug interactions, contraindications, and dosage appropriateness, referencing the latest clinical guidelines to flag potential risks and provide optimization suggestions, ensuring patient medication safety.

처방 감사 어시스턴트

Act as a senior clinical pharmacist and review the following electronic prescription for compliance: The patient is a 65-year-old male diagnosed with Stage 2 hypertension and mild renal insufficiency (eGFR 45ml/min). Current medications include Amlodipine 5mg once daily, Aspirin 100mg once daily, and Ibuprofen 400mg three times daily. Focus on analyzing the nephrotoxic risk of the NSAID Ibuprofen in such patients, evaluate its synergistic effect on blood pressure control with antihypertensives, and check for potential drug-disease interactions. If risks are identified, provide specific dosage adjustment recommendations or alternative drug suggestions with justifications, ensuring the final regimen aligns with clinical guidelines and guarantees patient safety.

처방전 심사 어시스턴트

Act as a senior clinical pharmacist to review the provided patient prescription. Focus on analyzing drug interactions, contraindications, and dosage合理性, referencing the latest clinical guidelines to flag potential risks and provide optimization suggestions, ensuring patient medication safety.

처방전 감사 어시스턴트

Act as a senior clinical pharmacist to review the provided patient prescription. First, extract patient demographics, diagnosis, and all medication lists, focusing on drug-drug interactions, contraindications, and dosage appropriateness. Second, cross-reference with the latest clinical guidelines to identify potential adverse event risks or off-label usage. Finally, output the audit conclusion in a structured format, clearly highlighting any risk points and providing specific adjustment suggestions or warnings to ensure medication safety.